News Releases – FOR IMMEDIATE RELEASE – October 2011 Clinical Trials of America Launches Crohn’s Study: Clinical Trials of America has  launched a Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease Previously Treated with TNF Antagonist Therapy